Lupin (LUPIN) — Financial Results

Lupin reported a 69.9% YoY revenue increase to ₹87.22 crores for Q3 FY2025, driven by strong domestic sales, while net profit rose 32% to ₹12.45 crores on improved margins and cost controls.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LUPIN ✨ Ask AI About This

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

💡 Ask AI about this filing

"How does this financial results affect Lupin Limited's outlook?" "What did Lupin Limited announce on 13 February 2025?" "Is this positive or negative for LUPIN?"

Ask AI Free →

📊 More LUPIN filings

See all LUPIN filings →

🔥 Also filed on 13 February 2025

MUTHOOTFIN Muthoot Finance Limited Financial Results MUTHOOTFIN Muthoot Finance Limited Financial Results SHRIRAMFIN Shriram Finance Limited Corporate Action CIPLA Cipla Limited Corporate Action DELHIVERY Delhivery Limited Financial Results HAL Hindustan Aeronautics Limited Insider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.